drugset / Trial / NCT01772563

Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours

NCT01772563

Phase 1 Completed 28 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of the present study is to investigate the influence of co-administration of itraconazole and volasertib on the pharmacokinetic profile of volasertib without co-administration of itraconazole. Secondary objectives are to investigate safety, tolerability and preliminary therapeutic effects following intravenous administration of volasertib.

Timeline

Start
2013-02-04
Primary completion
2014-05-30
Completion
2021-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject Volasertib Small molecule Intravenous

Indications